Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald W Dryden

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Inflammatory Bowel Diseases|July 13, 2013
A pilot study to evaluate the safety and efficacy of an oral dose of (-)-epigallocatechin-3-gallate-rich polyphenon E in patients with mild to moderate ulcerative colitisGerald W Dryden, Allan Lam, Karen Beatty, et al.
Journal of Clinical Gastroenterology|March 18, 2008
A novel classification scheme for gastroparesis based on predominant-symptom presentationSteven P Harrell, Jamie L Studts, Gerald W Dryden, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2016
Noninvasive Imaging of Colitis Using Multispectral Optoacoustic TomographyNeal Bhutiani, William E Grizzle, Susan Galandiuk, et al.
Gastrointestinal Endoscopy|May 8, 2026
Treatment of recurrent esophageal strictures with a paclitaxel coated balloon dilator: Initial U.S. ExperienceKenneth K Wang, Shahriar Sedghi, Gary T Reiss, et al.
BMJ Open|September 12, 2023
Development and validation of a product acceptability questionnaire for intranasal Q-Griffithsin COVID-19 prophylaxis (SPRAY PAL)Elizabeth Cash, Kailyn Deitz, Kevin L Potts, et al.
International Journal of Nanomedicine|July 3, 2013
Infrared light-absorbing gold/gold sulfide nanoparticles induce cell death in esophageal adenocarcinomaYan Li, Andre M Gobin, Gerald W Dryden, et al.
Inflammatory Bowel Diseases|December 23, 2017
Plasma microRNA Profile Differentiates Crohn's Colitis From Ulcerative ColitisUri Netz, Jane Carter, M Robert Eichenberger, et al.
Journal of Nanobiotechnology|November 13, 2024
Inflammation-targeted delivery of Urolithin A mitigates chemical- and immune checkpoint inhibitor-induced colitisSweta Ghosh, Rajbir Singh, Tanu Jain Goap, et al.
Theranostics|March 23, 2021
miR-375 prevents high-fat diet-induced insulin resistance and obesity by targeting the aryl hydrocarbon receptor and bacterial tryptophanase (<i>tnaA</i>) geneAnil Kumar, Yi Ren, Kumaran Sundaram, et al.
Nature Communications|June 23, 2026
Urolithin A activates aryl hydrocarbon receptor-NLRP6-mediated pathways in intestinal epithelial cells to modulate mucosal immunity and strengthen gut barrier integritySweta Ghosh, Zachary M Vanwinkle, Sobha Rani Bodduluri, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Inflammatory Bowel Diseases|July 13, 2013
A pilot study to evaluate the safety and efficacy of an oral dose of (-)-epigallocatechin-3-gallate-rich polyphenon E in patients with mild to moderate ulcerative colitisGerald W Dryden, Allan Lam, Karen Beatty, et al.
Journal of Clinical Gastroenterology|March 18, 2008
A novel classification scheme for gastroparesis based on predominant-symptom presentationSteven P Harrell, Jamie L Studts, Gerald W Dryden, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2016
Noninvasive Imaging of Colitis Using Multispectral Optoacoustic TomographyNeal Bhutiani, William E Grizzle, Susan Galandiuk, et al.
Gastrointestinal Endoscopy|May 8, 2026
Treatment of recurrent esophageal strictures with a paclitaxel coated balloon dilator: Initial U.S. ExperienceKenneth K Wang, Shahriar Sedghi, Gary T Reiss, et al.
BMJ Open|September 12, 2023
Development and validation of a product acceptability questionnaire for intranasal Q-Griffithsin COVID-19 prophylaxis (SPRAY PAL)Elizabeth Cash, Kailyn Deitz, Kevin L Potts, et al.
International Journal of Nanomedicine|July 3, 2013
Infrared light-absorbing gold/gold sulfide nanoparticles induce cell death in esophageal adenocarcinomaYan Li, Andre M Gobin, Gerald W Dryden, et al.
Inflammatory Bowel Diseases|December 23, 2017
Plasma microRNA Profile Differentiates Crohn's Colitis From Ulcerative ColitisUri Netz, Jane Carter, M Robert Eichenberger, et al.
Journal of Nanobiotechnology|November 13, 2024
Inflammation-targeted delivery of Urolithin A mitigates chemical- and immune checkpoint inhibitor-induced colitisSweta Ghosh, Rajbir Singh, Tanu Jain Goap, et al.
Theranostics|March 23, 2021
miR-375 prevents high-fat diet-induced insulin resistance and obesity by targeting the aryl hydrocarbon receptor and bacterial tryptophanase (<i>tnaA</i>) geneAnil Kumar, Yi Ren, Kumaran Sundaram, et al.
Nature Communications|June 23, 2026
Urolithin A activates aryl hydrocarbon receptor-NLRP6-mediated pathways in intestinal epithelial cells to modulate mucosal immunity and strengthen gut barrier integritySweta Ghosh, Zachary M Vanwinkle, Sobha Rani Bodduluri, et al.
Pageof 3